Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The GONDOLA™ device delivers AMPS therapy—a non-invasive mechanical stimulation to the feet—demonstrated to improve walking and balance impairments due to neurological disorders. Clinical research supports significant improvements for patients with Parkinson’s disease, stroke, and CIPN. The device has CE mark approval for Europe and FDA Breakthrough Device Designation in the US. It can be used at home or professionally. Benefits include reduced freezing of gait and improved independence. No major side effects reported.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gondola Medical Technologies.